Aisling Capital IV, LP 4
4 · Zosano Pharma Corp · Filed Dec 6, 2019
Insider Transaction Report
Form 4
Aisling Capital IV, LP
10% Owner
Transactions
- Award
Common Stock, par value of $0.0001
2019-12-02$1.45/sh+689,655$1,000,000→ 2,718,226 total
Footnotes (1)
- [F1]The securities are directly held by Aisling Capital IV, LP ("Aisling"), and may be deemed to be beneficially owned by Aisling Capital Partners IV, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners IV LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms.